OPROVDA Trademark

Trademark Overview

On Friday, April 22, 2022, a trademark application was filed for OPROVDA with the United States Patent and Trademark Office. The USPTO has given the OPROVDA trademark a serial number of 97377332. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 16, 2024. This trademark is owned by Global Blood Therapeutics, Inc.. The OPROVDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
oprovda

General Information

Serial Number97377332
Word MarkOPROVDA
Filing DateFriday, April 22, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, April 26, 2022NEW APPLICATION ENTERED
Thursday, April 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 9, 2023ASSIGNED TO EXAMINER
Thursday, February 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 4, 2023SOU EXTENSION 1 FILED
Wednesday, October 4, 2023SOU EXTENSION 1 GRANTED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024SOU EXTENSION 3 FILED
Wednesday, October 16, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 10, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 10, 2024SOU EXTENSION 2 FILED
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

oprovda pharmaceutical treatment preparations cell disease hypoxemic conditions sickle hypoxic disorders